Navigation Links
PDL BioPharma Provides First Quarter 2011 Revenue Guidance of $83 Million
Date:3/7/2011

INCLINE VILLAGE, Nev., March 7, 2011 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the first quarter ending March 31, 2011 of approximately $83 million, as compared with actual results of $62 million for the first quarter of 2010, an expected 34 percent year-over-year increase.  Included in first quarter revenue guidance is the $10 million settlement received from UCB Pharma S.A. (UCB) in January 2010 resolving all legal disputes between the two companies, including those relating to UCB's pegylated humanized antibody fragment, Cimzia®, and PDL's patents known as the Queen et al. patents.

Royalty revenues included in first quarter 2011 revenue guidance are $73 million as compared with actual royalty revenues of $62 million for the first quarter of 2010, an expected 18 percent year-over-year increase. The forecasted growth is primarily driven by increased fourth quarter 2010 sales of Herceptin®, Lucentis® and Tysabri® for which PDL received royalties in the first quarter of 2010.  Also contributing to the expected increase are increased royalties from sales of Avastin® that was both manufactured and sold outside of the United States.  Ex-U.S. manufactured and sold Avastin sales represented 19 percent of total Avastin sales in the fourth quarter of 2010 as compared with five percent of total Avastin sales for same period in 2009. The first quarter royalty payment recently received from Genentech included royalties generated on all worldwide sales.

Sales of Avastin, Herceptin and Lucentis are subject to a tiered royalty rate for product that is made or sold in the United States and a flat royalty rate of three percent for product that is manufactured and sold outside of the United States.  The net sales thresholds and the applicable royalty rates for product that is m
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
(Date:8/31/2015)... PLEASANTON, Calif. , Aug. 31, 2015  QT Vascular ... "QT Vascular", and together with its subsidiaries, the ... assembly and distribution of advanced therapeutic solutions for ... today the final results of the below-the-knee ("BTK") ... Registry ("BAR") which were presented on August 15, ...
(Date:8/31/2015)... Aug. 31, 2015   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell ... cryopreservation freeze media and a related ... for smart shippers ("BioLife" or the ... an advanced biopharmaceutical company focused on developing and ...
Breaking Medicine Technology:Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... Va., Feb. 9, 2011 With generous funding ... Palliative Care Association are partnering to improve pain ... hospitals in The Gambia, Kenya, and Malawi. ... they each have well-established national palliative care organizations, ...
... Design Trends: Technological Advances in Implantable Devices, a UBM Canon Medical Device ... Industry ( MD+DI ) , ... , and OrthoTec , is now on-demand ... 1,092, with an attendance of 50% during the live event held on ...
Cached Medicine Technology:FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi 2Now Available: Archived Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 2Now Available: Archived Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 3
(Date:9/1/2015)... MO (PRWEB) , ... September 01, 2015 , ... ... Wednesday, September 9, 2015 from 5:00 to 8:00 pm at the Marriott Indianapolis ... and groups with career opportunities will be attending from across the country. All ...
(Date:9/1/2015)... ... 01, 2015 , ... Dr. Trace Curry successfully placed one of the first ... last month the FDA has approved two intra-gastric balloons, the ORBERA ™ Managed ... first incisionless, reversible, weight loss procedures available to Americans. , Dr. Curry, ...
(Date:9/1/2015)... ... ... Elizabeth Callahan, MD, founder and medical director of SkinSmart Dermatology® , is ... treatment for volume loss in the hands. RADIESSE provides an immediate volumizing effect and ... smooth, natural-looking results that can last up to one year in most patients. Treating ...
(Date:9/1/2015)... ... ... September is Baby Safety Month, and Lightning Labels wants to ... ones' safety top of mind at all times. , Sponsored by the Juvenile Products ... JPMA's Baby Safety Zone website, this year's theme is A Room with A Safe ...
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry is an organized system ... therapy patients. The Registry is being developed by the American Physical Therapy Association (APTA). ... to be selected to contribute FOTO Outcomes measures as one of the primary global ...
Breaking Medicine News(10 mins):Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2
... ... available on XM Satellite Radio Channel 160. This program is produced by KarenZupko & ... ReachMD, a new media communications platform for medical professionals. , ... Chicago, IL (PRWEB) July 15, 2009 ...
... ... the third fastest growing private company by the Indianapolis Business Journal. Mainstreet is a ... since 2006, and from 4 to 145 employees. , ... Cicero, IN (PRWEB) July 15, 2009 -- Mainstreet Property Group ...
... ... application backlogs rise, the impact on people with disabilities grows and adds to financial ... Belleville, ... rate in nine months, according to a quarterly study by Allsup , a ...
... , , , ... in "International Immunopharmacology," reveals why Pycnogenol(R) (pic-noj-en-all), an antioxidant plant ... is effective for reducing inflammation and soothing pain associated with ... Research Institute on Food and Nutrition in Rome, Italy, found ...
... , SAN DIEGO, July 14 CareFusion ... Cardinal Health,s clinical and medical products businesses, today announced the pricing ... notes. The notes consist of the following tranches: , ... principal amount of 4.125% senior notes due 2012 , ...
... , , State must comply - NOT ... OAKLAND, Calif., July 14 In a ruling issued late yesterday ... her June 25, 2009, ruling which halts the State,s plans to cut In-Home ... ruling sends a clear message to the Governor that you can,t ignore the ...
Cached Medicine News:Health News:KarenZupko & Associates, Inc. and ReachMD XM 160 Announce New Radio Programming Series, "Practice Success" hosted by Karen Zupko 2Health News:KarenZupko & Associates, Inc. and ReachMD XM 160 Announce New Radio Programming Series, "Practice Success" hosted by Karen Zupko 3Health News:Growth Despite Economy; Mainstreet Property Group Named One of Indiana's Fastest Growing Companies 2Health News:Growth Despite Economy; Mainstreet Property Group Named One of Indiana's Fastest Growing Companies 3Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 2Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 3Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 4Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 5Health News:Study Demonstrates the Anti-Inflammatory Properties of Pine Bark Extract on Inflammatory Mediators COX-2 and 5-LOX 2Health News:Study Demonstrates the Anti-Inflammatory Properties of Pine Bark Extract on Inflammatory Mediators COX-2 and 5-LOX 3Health News:CareFusion Prices $1.4 Billion of Senior Notes 2Health News:Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: